VRDN
#1997
Viridian Therapeutics, Inc. - Common Stock
19.0 8 USD
0.00%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
+0.47%
Monthly Change
+17.13%
6 month change
-42.32%
Year Change
-15.01%
Previous Close
18.9 9
Open
19.0 8
Low
19.0 8
High
19.0 8
Volume
167
Financials
- Market Capitalization 1.97 B
- Employee 252
- Founded 2010
- CEO N/A
- Website www.viridiantherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG002H242Z5
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
—
Price to sales ratio
—
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 1984 |  HRMY Harmony Biosciences Holdings, Inc. - Common Stock | 34.81 USD | -2.05% | -8.30% | +1.25% | +12.65% | 2.02 B USD | ||
| 1992 |  GLUE Monte Rosa Therapeutics, Inc. - Common Stock | 23.46 USD | +6.73% | -2.21% | +30.04% | +107.61% | 1.98 B USD | ||
| 2005 |  TYRA Tyra Biosciences, Inc. - Common Stock | 32.88 USD | +0.64% | +3.07% | +15.17% | +129.29% | 1.96 B USD | ||
| 2012 |  SION Sionna Therapeutics, Inc. - Common Stock | 42.59 USD | -3.09% | -4.25% | +18.27% | +8.26% | 1.92 B USD |
Frequently asked questions about Viridian Therapeutics, Inc. - Common Stock
What is the Viridian Therapeutics, Inc. - Common Stock stock price today?
The current price of Viridian Therapeutics, Inc. - Common Stock (VRDN) is 19.08. Over the past 24 hours, the stock has changed by +0.47%. Follow the VRDN chart for real-time price dynamics.
What is the stock ticker of Viridian Therapeutics, Inc. - Common Stock?
Viridian Therapeutics, Inc. - Common Stock trades under the ticker VRDN. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Viridian Therapeutics, Inc. - Common Stock stock going up?
VRDN has changed by -5.17% over the last week, +17.13% over the last month, and -15.01% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Viridian Therapeutics, Inc. - Common Stock net income for the last quarter?
Viridian Therapeutics, Inc. - Common Stock reported net income of -104.9 M for the last quarter. The previous quarter showed -120.36 M, which means net income changed by +12.84%.
How many employees does Viridian Therapeutics, Inc. - Common Stock have?
As of the latest available data, Viridian Therapeutics, Inc. - Common Stock has 252 employees. Workforce size can provide additional context about the company's scale and operations.
What is Viridian Therapeutics, Inc. - Common Stock EBITDA?
Viridian Therapeutics, Inc. - Common Stock EBITDA is -116.05 M, and its EBITDA margin is -82.3 K%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Viridian Therapeutics, Inc. - Common Stock stock?
You can buy Viridian Therapeutics, Inc. - Common Stock (VRDN) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Viridian Therapeutics, Inc. - Common Stock stock?
Investing in Viridian Therapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the VRDN chart and related analysis on metatrader.com as part of your research.